Skip to main content
| Hans-Günter Meyer-Thompson | Hepatitiden

Clinical and patient reported outcomes of direct-acting antivirals for the treatment of chronic hepatitis C among patients in opioid agonist treatment: A real-world prospective cohort study

Clinical and patient reported outcomes of direct-acting antivirals for the treatment of chronic hepatitis C among patients in opioid agonist treatment: A real-world prospective cohort study

Bernd Schulte, Christiane S Schmidt, Jakob Manthey, Lisa Strada, Stefan Christensen, Konrad Cimander, Herbert Görne, Pavel Khaykin, Norbert Scherbaum, Stefan Walcher, Stefan Mauss, Ingo Schäfer, Uwe Verthein, Jürgen Rehm, Jens Reimer, 

Open Forum Infectious Diseases, , ofaa317, doi.org/10.1093/ofid/ofaa317

Clinical and patient reported outcomes of direct-acting antivirals for the treatment of chronic hepatitis C among patients in opioid agonist treatment: A real-world prospective cohort study